Russian Railways, Belarusian Railway and FESCO Arranged the First Fully Digitalized Transit Transportation between Asia and Europe 

MOSCOW, Sept. 3, 2020 /PRNewswire/ -- A pilot intermodal container transportation was carried out on September 3 from the Port of Ningbo in China through the Port of Vladivostok in Russia to the Kolyadichi station in Belarus as part of the...

MOSCOW, Sept. 3, 2020 /PRNewswire/ — A pilot intermodal container transportation was carried out on September 3 from the Port of Ningbo in China through the Port of Vladivostok in Russia to the Kolyadichi station in Belarus as part of the INTERTRAN project. 

This transportation became the first completely digitalized transit container shipment between Asia and Europe arranged by Russian Railways, Belarusian Railway and FESCO Transportation Group. 

INTERTRAN technology has already been replicated throughout the Russian Railways network, and over 6,000 containers have been transported with this service. 

The service reduced the time required for processing freight documents by four days. It was the use of solely electronic transport documents, transit declarations and electronic customs clearance that made it possible. 

The positive effects of the INTERTRAN project were particularly evident during the COVID-19 pandemic, because digital processing reduced physical contacts during transportation to a minimum. 

The INTERTRAN project was presented at the 5th Eastern Economic Forum in September 2019. The electronic system is designed to develop intermodal transportation in Eurasia, reduce paperwork, and accelerate interactions between all parties in the transportation process. These shipments are being carried out on a regular basis from Japan, China, and South Korea. 

 

Leggi anche...
I più recenti

Sindrome da chilomicronemia familiare: l’EMA approva il nuovo farmaco Redemplo

Giappone, cresce il ruolo dei CDMO nello sviluppo dei farmaci a base di peptidi

Accesso alle terapie oncologiche mirate in Italia: un potenziale ancora inespresso

Endometriosi: avviata la fase 2 del trial NOVA con vipoglanstat di Gesynta Pharma

Newsletter

Iscriviti ora per rimanere aggiornato su tutti i temi inerenti la salute.